Intriguingly, consistent with previous observation of elevated C5a expression in the serum of AMD patients [15,16], we found significantly increased levels of IL-22 and IL-17 in the sera of AMD patients, suggesting possible roles of IL-22 and IL-17 in the inflammation that contributes to AMD. This evidence concerns the gene IL22 and age-related macular degeneration.